Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 119610
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.119610
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.119610
Figure 1 Kaplan-Meier 2- and 5-year survival curve after pancreaticoduodenectomy for pancreatic cancer.
A: Kaplan-Meier 2-year survival curve after pancreaticoduodenectomy for pancreatic cancer; B: Kaplan-Meier 5-year survival curve after pancreaticoduodenectomy for pancreatic cancer.
Figure 2 Kaplan-Meier 2- and 5-year survival curve considering carbohydrate antigen 19-9 and carcinoembryonic antigen values after pancreaticoduodenectomy for pancreatic cancer.
A: Kaplan-Meier 2- and 5-year survival curve considering carbohydrate antigen 19-9 values after pancreaticoduodenectomy for pancreatic cancer; B: Kaplan-Meier 2- and 5-year survival curve considering carcinoembryonic antigen values after pancreaticoduodenectomy for pancreatic cancer. CA 19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen.
- Citation: Trogrlić B, Požgain Z, Augustin G, Kovačić B, Hil D, Šerić I, Šikić V. Diagnostic and prognostic values of pancreatic juice carbohydrate antigen 19-9 and carcinoembryonic antigen levels in patients with pancreatic cancer. World J Gastrointest Oncol 2026; 18(5): 119610
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/119610.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.119610